SILO PHARMA, INC. Equity Method Investment, Ownership Percentage
SILO PHARMA, INC. (SILO) had Equity Method Investment, Ownership Percentage of 10.00% as of 2020-12-31, per its 10-K/A filed 2021-05-17.
Discontinued › Notes › Investments › Equity Method Investments and Joint Ventures
us-gaap:EquityMethodInvestmentOwnershipPercentage · last filed 2021-05-17
- 2020-12-31: Equity Method Investment, Ownership Percentage 10.00%.
- 2017-03-31: Equity Method Investment, Ownership Percentage 78.00%.
| Period end | Equity Method Investment, Ownership Percentage |
|---|---|
| 2020-12-31 | 10.00% 10-K/A · filed 2021-05-17 |
| 2017-03-31 | 78.00% 10-K · filed 2020-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |